Macatawa Bank (MCBC) Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Macatawa Bank in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MCBC shares.
View MCBC analyst ratings or view top-rated stocks.

1 brokerages have issued 1-year price targets for Macatawa Bank's stock. Their MCBC share price forecasts range from $11.00 to $11.00. On average, they anticipate the company's stock price to reach $11.00 in the next year. This suggests a possible upside of 21.4% from the stock's current price.
View analysts price targets for MCBC or view top-rated stocks among Wall Street analysts.

Macatawa Bank's stock was trading at $11.03 on January 1st, 2023. Since then, MCBC shares have decreased by 17.9% and is now trading at $9.06.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our MCBC earnings forecast.

Macatawa Bank Co. (NASDAQ:MCBC) issued its earnings results on Thursday, July, 27th. The financial services provider reported $0.30 EPS for the quarter. The financial services provider earned $25.76 million during the quarter. Macatawa Bank had a trailing twelve-month return on equity of 17.65% and a net margin of 37.13%.

Macatawa Bank announced a quarterly dividend on Thursday, July 20th. Investors of record on Tuesday, August 15th will be given a dividend of $0.08 per share on Wednesday, August 30th. This represents a $0.32 annualized dividend and a dividend yield of 3.53%. The ex-dividend date of this dividend is Monday, August 14th.
Read our dividend analysis for MCBC.

Macatawa Bank (NASDAQ:MCBC) pays an annual dividend of $0.32 per share and currently has a dividend yield of 3.55%. The dividend payout ratio is 24.81%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MCBC will have a dividend payout ratio of 26.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MCBC.

9 employees have rated Macatawa Bank Chief Executive Officer Ronald L. Haan on Glassdoor.com. Ronald L. Haan has an approval rating of 74% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Macatawa Bank investors own include Mercantile Bank (MBWM), Nokia Oyj (NOK), AT&T (T), Weatherford International (WFT), People's United Financial (PBCT), Public Storage (PSA), Huntington Bancshares (HBAN), International Business Machines (IBM), New York Community Bancorp (NYCB) and Pfizer (PFE).

Macatawa Bank trades on the NASDAQ under the ticker symbol "MCBC."

Macatawa Bank's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (4.52%), Dimensional Fund Advisors LP (4.49%), Alliancebernstein L.P. (4.05%), Renaissance Technologies LLC (2.53%), State Street Corp (1.62%) and Geode Capital Management LLC (1.49%).
View institutional ownership trends.

Shares of MCBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MCBC stock can currently be purchased for approximately $9.06.

Macatawa Bank (NASDAQ:MCBC) has a market capitalization of $310.67 million and generates $94.93 million in revenue each year. The financial services provider earns $34.73 million in net income (profit) each year or $1.29 on an earnings per share basis.

The company employs 287 workers across the globe.

Macatawa Bank's mailing address is 10753 MACATAWA DRIVE, HOLLAND MI, 49424. The official website for the company is www.macatawabank.com. The financial services provider can be reached via phone at (616) 820-1444, via email at jswets@macatawabank.com, or via fax at 616-494-7644.